Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bausch & Lomb

This article was originally published in The Tan Sheet

Executive Summary

Sales from continuing businesses for the fiscal fourth quarter ended Dec. 25 totaled $466.6 mil., up 8.9%. Excluding foreign exchange rates, sales increased 11% over the prior-year period. After restructuring charges and the results of discontinued operations, net income for the quarter was $17.2 mil. For the year, sales rose 9.9% to $1.76 bil. Factoring in restructuring charges, a gain on redemption of securities in the third quarter and purchase accounting adjustments and write-offs from 1998, net income reached $444.8 mil. for the year. Bausch & Lomb vision care revenues rose 6% for the quarter, while pharmaceutical sales rose 12%. Domestic sales accounted for 51% of total revenues and jumped 11% in the quarter
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090828

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel